(Q24245175)

3

object named as

Michael E. Thase

0 references

author name string

Cheryl A Chessick

1

0 references

Michael H Allen

2

0 references

Angelo ABC Batista Miralha da Cunha

4

0 references

Mauricio Silva de Lima

6

0 references

Juliano JSS dos Santos Souza

Cochrane Database of Systematic Reviews

7

0 references

language of work or name

English

0 references

publication date

19 July 2006

0 references

published in

0 references

page(s)

CD006115

0 references

issue

3

0 references

cites work

Controlled comparison of buspirone and oxazepam in generalized anxiety.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006115

Treatment of generalised anxiety disorder with a short course of psychological therapy, combined with buspirone or placebo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006115

Double-blind comparison of buspirone and clorazepate in anxious outpatients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006115

A pooled, double-blind comparison of the effects of buspirone, diazepam and placebo in women with chronic anxiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006115

A phase II multicenter dose-finding, efficacy and safety trial of ipsapirone in outpatients with generalized anxiety disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006115

Alprazolam versus buspirone in the treatment of outpatients with generalized anxiety disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006115

Efficacy and safety of lesopitron in outpatients with generalized anxiety disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006115

Comparison of buspirone and diazepam in generalized anxiety disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006115

The effect of social factors on the anxiolytic efficacy of buspirone in male rats, male mice, and men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006115

Comparative assessment of efficacy and withdrawal symptoms after 6 and 12 weeks' treatment with diazepam or buspirone

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006115

21 January 2018

Buspirone: anxiolytic?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006115

Evaluation of buspirone as an antianxiety agent: buspirone and diazepam versus placebo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006115

Gepirone and diazepam in generalized anxiety disorder: a placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006115

A clinical trial of buspirone and diazepam in the treatment of generalized anxiety disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006115

Efficacy and safety of two dosing regimens of buspirone in the treatment of outpatients with persistent anxiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006115

Comparison of withdrawal of buspirone and diazepam: a placebo controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006115

Differential effects of the anxiolytic drugs, diazepam and buspirone, on memory function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006115

Long-term Treatment of Anxiety and Risk of Withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006115

Establishing the maximum tolerated dose of lesopitron in patients with generalized anxiety disorder: a bridging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006115

Anxiety in primary care: Is short-term drug treatment appropriate?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006115

Pharmacologic treatment of generalized anxiety disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006115

Influence of psychiatric comorbidity on recovery and recurrence in generalized anxiety disorder, social phobia, and panic disorder: a 12-year prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006115

Use of buspirone in patients with generalized anxiety disorder and coexisting depressive symptoms. A meta-analysis of eight randomized, controlled studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006115

The assessment of anxiety states by rating

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006115

Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006115

Use of benzodiazepines in anxiety disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006115

DSM-III-R generalized anxiety disorder in the National Comorbidity Survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006115

Long-term treatment of anxiety and risk of withdrawal. Prospective comparison of clorazepate and buspirone

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006115

7 January 2021

Buspirone and lorazepam in the treatment of generalized anxiety disorder in outpatients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006115

7 January 2021

A multicentre double-blind comparison of hydroxyzine, buspirone and placebo in patients with generalized anxiety disorder

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006115

7 January 2021

Controlled comparison of the effects and abrupt discontinuation of buspirone and lorazepam

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006115

7 January 2021

Efficacy of applied relaxation and cognitive-behavioral therapy in the treatment of generalized anxiety disorder

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006115

7 January 2021

Assessment of the Efficacy of Buspirone in Patients Affected by Generalized Anxiety Disorder, Shifting to Buspirone From Prior Treatment with Lorazepam

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006115

7 January 2021

Placebo-controlled comparison of the clinical effects of rapid discontinuation of ipsapirone and lorazepam after 8 weeks of treatment for generalized anxiety disorder

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006115

7 January 2021

Analysis of individual symptoms in generalized anxiety--a pooled, multistudy, double-blind evaluation of buspirone

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006115

7 January 2021

Imipramine and buspirone in treatment of patients with generalized anxiety disorder who are discontinuing long-term benzodiazepine therapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006115

7 January 2021

Efficacy, safety, and tolerability of venlafaxine extended release and buspirone in outpatients with generalized anxiety disorder

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006115

7 January 2021

Prior benzodiazepine use and buspirone response in the treatment of generalized anxiety disorder

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006115

7 January 2021

Pattern of symptom improvement following treatment with venlafaxine XR in patients with generalized anxiety disorder.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006115

7 January 2021

Antidepressants for generalised anxiety disorder (GAD)

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1002/14651858.CD003592

Identifiers

DOI

10.1002/14651858.CD006115

0 references

Fatcat ID

release_eu3o6tmclrb6bhdm3ilzg3tiie

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/eu3o6tmclrb6bhdm3ilzg3tiie

24 November 2022

mapped directly with Wikidata item

1 reference

https://api.fatcat.wiki/v0/release/eu3o6tmclrb6bhdm3ilzg3tiie

24 November 2022